Skip to main content

and
  1. Article

    Open Access

    Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective

    Gliflozins have historically been indicated for type 2 diabetes in France. However, their efficacy has recently been demonstrated in heart failure and chronic kidney disease (CKD), with positive recommendation...

    Gérard de Pouvourville, Patrick Rossignol, Meriem Boussahoua in Advances in Therapy (2023)